市場調査レポート
商品コード
1404657

細胞培養培地の市場規模、シェア、動向分析レポート:製品タイプ別、用途別、最終用途別、地域別、セグメント別予測、2024年~2030年

Cell Culture Media Market Size, Share & Trends Analysis Report By Product (Serum-free Media, Stem Cell Culture Media), By Type (Liquid Media, Semi-solid And Solid Media), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 150 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
細胞培養培地の市場規模、シェア、動向分析レポート:製品タイプ別、用途別、最終用途別、地域別、セグメント別予測、2024年~2030年
出版日: 2023年11月13日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

細胞培養培地市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界の細胞培養培地市場規模は、2024年から2030年にかけて12.54%のCAGRを記録し、2030年には107億米ドルに達すると予測されています。

バイオシミラーや生物製剤の拡大、幹細胞研究の成長、細胞由来ワクチンのバイオ製造技術の台頭が市場を牽引する主な要因です。例えば、2021年10月、オーストラリア政府はオーストラリア主導の幹細胞研究に2,500万米ドルの助成金を提供しました。

新興市場におけるバイオシミラーの明確な承認経路の拡大は、バイオシミラーモノクローナル抗体に大きな機会をもたらしています。米国で承認パスウェイが利用可能になったことで、バイオ・メーカーは世界の主要市場に参入する新たな機会を得ています。モノクローナル抗体のバイオシミラー製剤は、25~30%のコスト削減を実現する可能性があり、多くの新興市場諸国が承認への道筋を精力的に開拓し、急速に追いついています。この産業が拡大するにつれて、主要なバイオ医薬品メーカーは需要の増加に対応するために強固な培養技術を採用し、市場の成長を牽引しています。

さらに、幹細胞培養の改良に対する関心も高まっています。この技術は、幹細胞の生物学的研究だけでなく、治療への応用にも広く使用されているからです。さらに、この研究分野に関連する資金は近年増加しており、これが市場の成長を加速させています。これに加えて、主要な培地メーカーが幹細胞調査用の新製品を発売しました。例えば、2021年9月、Bio-Techne Corporationは、トランスレーショナルワークフローとリサーチワークフローの両方に応用できる人工多能性幹細胞の維持と増殖のための新規培地を発売しました。

COVID-19パンデミックの発生は、確立された細胞ベースのワクチン生産技術に対する需要を向上させました。さらに、特にワクチン技術の生産と試験において、いくつかの科学的革新をもたらしました。例えば、Vero株はアフリカミドリザルの腎臓に由来し、ウイルスワクチン製造に広く使用されています。また、様々なSARS-CoV変異体の開発にも使用されています。ProVeroTM1 Serum-free培地は、Lonza Bioscience社が製造するそのような培地の一つで、Vero細胞やMDCKの増殖をサポートするように設計された、タンパク質を含まない非動物由来の培地です。

さらに、欧州の多くの国では、細胞ベースのインフルエンザ・ワクチンが承認されています。細胞培養技術の利点は、パンデミック時にワクチン製造をより早く開始できることであろう。今日、優れた生物学的モデルの開発、培養増殖液の最適化、動物由来成分への依存度の低減が、急速に発展するワクチン開発の原動力となっています。

その一方で、動物由来製品の使用に関する倫理的問題が業界の成長を妨げています。例えば、FBSが子牛胎児の血液から採取されることは、血清含有培地の倫理的な主要問題の一つです。世界では毎年、最大180万頭のウシ胎児から60万リットルのFBSが生産されると予測されており、科学的・倫理的に重大な課題を提示しています。この問題を克服するため、牛胎児血清の代替や培地中のFBSの使用を減らす可能な方法について、過去に数多くのワークショップが開催されました。

細胞培養培地市場レポートハイライト

  • 製品別では、無血清培地(SFM)セグメントが2023年に36.0%の最高市場シェアを占めました。無血清培地の使用は、研究者が血清を使用せずに特定のアプリケーションを実行したり、特定の細胞タイプを増殖させたりすることを可能にする重要なツールを意味します。
  • バイオ医薬品生産部門は、2023年に42.71%の収益シェアで市場を独占しました。主要バイオ医薬品企業による戦略的活動、研究開発の増加、より再現性が高く、より明確に定義された培地への需要、バイオシミラー市場の拡大が、このセグメントの成長を牽引しています。
  • タイプ別では、液体培地セグメントが2023年に62.9%の最高売上シェアを獲得しました。これは、川下および川上のバイオ医薬品メーカーが、プレミックス粉末から液体培地への切り替えを進めており、市場成長を後押ししているためです。
  • 最終用途別では、製薬企業およびバイオテクノロジー企業が2023年に34.25%の最高収益シェアを獲得しました。
  • 北米は、製薬・バイオテクノロジー産業の成長、高水準の研究開発投資の存在、新興国市場での新規培地製品の開発により、2023年に37.58%の売上高シェアで地域市場を独占しました。
  • アジア太平洋は、細胞培養技術の使用に関連する意識の高まりにより、推定・予測期間中に14.92%のCAGRで最速成長します。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 付随市場の見通し
  • 市場動向と展望
  • 市場力学
    • 市場促進要因の影響分析
    • 市場抑制要因の影響分析
  • 事業環境分析
    • SWOT分析;要因別(政治・法律、経済・技術)
    • ポーターのファイブフォース分析
  • 主要市場参入企業による最近の動向と影響分析
    • 合併と買収
    • 技術提携
    • ライセンシングとパートナーシップ
  • COVID-19感染症の影響分析

第4章 製品ビジネス分析

  • 製品変動分析と市場シェア、2023年と2030年
  • 無血清培地
    • CHO培地
    • HEK 293培地
    • BHK培地
    • ベロミディアム
    • その他の無血清培地
  • 従来型培地
  • 幹細胞培養培地
  • 化学的定義媒体
  • 専門培地
  • その他の細胞培養培地

第5章 タイプビジネス分析

  • タイプの変動分析と市場シェア、2023年と2030年
  • 液体媒体
  • 半固体および固体メディア

第6章 用途ビジネス分析

  • 用途の変動分析と市場シェア、2023年と2030年
  • バイオ医薬品の生産
    • モノクローナル抗体
    • ワクチンの製造
    • その他の治療用タンパク質
  • 診断
  • 薬剤のスクリーニングと開発
  • 組織工学と再生医療
    • 細胞および遺伝子治療
    • その他の組織工学および再生医療
  • その他の用途

第7章 エンドユーザービジネス分析

  • エンドユーザーの変動分析と市場シェア、2023年と2030年
  • 製薬およびバイオテクノロジー企業
  • 病院と診断研究所
  • 研究および学術機関
  • その他のエンドユーザー

第8章 細胞培養培地市場:製品、タイプ、用途、最終用途別の地域推定・動向分析

  • 細胞培養培地市場:地域別展望
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第9章 競合情勢

  • 企業の分類
  • 戦略マッピング
  • 企業の市況分析、2023年
  • 企業プロファイル・一覧表
    • Sartorius AG
    • Danaher
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • FUJIFILM Corporation
    • Lonza
    • BD
    • STEMCELL Technologies
    • Cell Biologics, Inc.
    • PromoCell GmbH
図表

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Cell Culture Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 4. Global Cell Culture Media Market, by Type, 2018 - 2030 (USD Million)
  • Table 5. Global Cell Culture Media Market, by Application, 2018 - 2030 (USD Million)
  • Table 6. Global Cell Culture Media Market, by End-use, 2018 - 2030 (USD Million)
  • Table 7. Global Cell Culture Media Market, by Region, 2018 - 2030 (USD Million)
  • Table 8. North America Cell Culture Media Market, by Country, 2018 - 2030 (USD Million)
  • Table 9. North America Cell Culture Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 10. North America Cell Culture Media Market, by Type, 2018 - 2030 (USD Million)
  • Table 11. North America Cell Culture Media Market, by Application, 2018 - 2030 (USD Million)
  • Table 12. North America Cell Culture Media Market, by End-use, 2018 - 2030 (USD Million)
  • Table 13. U.S. Cell Culture Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 14. U.S. Cell Culture Media Market, by Type, 2018 - 2030 (USD Million)
  • Table 15. U.S. Cell Culture Media Market, by Application, 2018 - 2030 (USD Million)
  • Table 16. U.S. Cell Culture Media Market, by End-use, 2018 - 2030 (USD Million)
  • Table 17. Canada Cell Culture Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 18. Canada Cell Culture Media Market, by Type, 2018 - 2030 (USD Million)
  • Table 19. Canada Cell Culture Media Market, by Application, 2018 - 2030 (USD Million)
  • Table 20. Canada Cell Culture Media Market, by End-use, 2018 - 2030 (USD Million)
  • Table 21. Europe Cell Culture Media Market, by Country, 2018 - 2030 (USD Million)
  • Table 22. Europe Cell Culture Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 23. Europe Cell Culture Media Market, by Type, 2018 - 2030 (USD Million)
  • Table 24. Europe Cell Culture Media Market, by Application, 2018 - 2030 (USD Million)
  • Table 25. Europe Cell Culture Media Market, by End-use, 2018 - 2030 (USD Million)
  • Table 26. Germany Cell Culture Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 27. Germany Cell Culture Media Market, by Type, 2018 - 2030 (USD Million)
  • Table 28. Germany Cell Culture Media Market, by Application, 2018 - 2030 (USD Million)
  • Table 29. Germany Cell Culture Media Market, by End-use, 2018 - 2030 (USD Million)
  • Table 30. UK Cell Culture Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 31. UK Cell Culture Media Market, by Type, 2018 - 2030 (USD Million)
  • Table 32. UK Cell Culture Media Market, by Application, 2018 - 2030 (USD Million)
  • Table 33. UK Cell Culture Media Market, by End-use, 2018 - 2030 (USD Million)
  • Table 34. France Cell Culture Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 35. France Cell Culture Media Market, by Type, 2018 - 2030 (USD Million)
  • Table 36. France Cell Culture Media Market, by Application, 2018 - 2030 (USD Million)
  • Table 37. France Cell Culture Media Market, by End-use, 2018 - 2030 (USD Million)
  • Table 38. Italy Cell Culture Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 39. Italy Cell Culture Media Market, by Type, 2018 - 2030 (USD Million)
  • Table 40. Italy Cell Culture Media Market, by Application, 2018 - 2030 (USD Million)
  • Table 41. Italy Cell Culture Media Market, by End-use, 2018 - 2030 (USD Million)
  • Table 42. Spain Cell Culture Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 43. Spain Cell Culture Media Market, by Type, 2018 - 2030 (USD Million)
  • Table 44. Spain Cell Culture Media Market, by Application, 2018 - 2030 (USD Million)
  • Table 45. Spain Cell Culture Media Market, by End-use, 2018 - 2030 (USD Million)
  • Table 46. Denmark Cell Culture Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 47. Denmark Cell Culture Media Market, by Type, 2018 - 2030 (USD Million)
  • Table 48. Denmark Cell Culture Media Market, by Application, 2018 - 2030 (USD Million)
  • Table 49. Denmark Cell Culture Media Market, by End-use, 2018 - 2030 (USD Million)
  • Table 50. Norway Cell Culture Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 51. Norway Cell Culture Media Market, by Type, 2018 - 2030 (USD Million)
  • Table 52. Norway Cell Culture Media Market, by Application, 2018 - 2030 (USD Million)
  • Table 53. Norway Cell Culture Media Market, by End-use, 2018 - 2030 (USD Million)
  • Table 54. Sweden Cell Culture Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 55. Sweden Cell Culture Media Market, by Type, 2018 - 2030 (USD Million)
  • Table 56. Sweden Cell Culture Media Market, by Application, 2018 - 2030 (USD Million)
  • Table 57. Sweden Cell Culture Media Market, by End-use, 2018 - 2030 (USD Million)
  • Table 58. Asia Pacific Cell Culture Media Market, by Country, 2018 - 2030 (USD Million)
  • Table 59. Asia Pacific Cell Culture Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 60. Asia Pacific Cell Culture Media Market, by Type, 2018 - 2030 (USD Million)
  • Table 61. Asia Pacific Cell Culture Media Market, by Application, 2018 - 2030 (USD Million)
  • Table 62. Asia Pacific Cell Culture Media Market, by End-use, 2018 - 2030 (USD Million)
  • Table 63. China Cell Culture Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 64. China Cell Culture Media Market, by Type, 2018 - 2030 (USD Million)
  • Table 65. China Cell Culture Media Market, by Application, 2018 - 2030 (USD Million)
  • Table 66. China Cell Culture Media Market, by End-use, 2018 - 2030 (USD Million)
  • Table 67. Japan Cell Culture Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 68. Japan Cell Culture Media Market, by Type, 2018 - 2030 (USD Million)
  • Table 69. Japan Cell Culture Media Market, by Application, 2018 - 2030 (USD Million)
  • Table 70. Japan Cell Culture Media Market, by End-use, 2018 - 2030 (USD Million)
  • Table 71. India Cell Culture Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 72. India Cell Culture Media Market, by Type, 2018 - 2030 (USD Million)
  • Table 73. India Cell Culture Media Market, by Application, 2018 - 2030 (USD Million)
  • Table 74. India Cell Culture Media Market, by End-use, 2018 - 2030 (USD Million)
  • Table 75. South Korea Cell Culture Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 76. South Korea Cell Culture Media Market, by Type, 2018 - 2030 (USD Million)
  • Table 77. South Korea Cell Culture Media Market, by Application, 2018 - 2030 (USD Million)
  • Table 78. South Korea Cell Culture Media Market, by End-use, 2018 - 2030 (USD Million)
  • Table 79. Australia Cell Culture Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 80. Australia Cell Culture Media Market, by Type, 2018 - 2030 (USD Million)
  • Table 81. Australia Cell Culture Media Market, by Application, 2018 - 2030 (USD Million)
  • Table 82. Australia Cell Culture Media Market, by End-use, 2018 - 2030 (USD Million)
  • Table 83. Thailand Cell Culture Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 84. Thailand Cell Culture Media Market, by Type, 2018 - 2030 (USD Million)
  • Table 85. Thailand Cell Culture Media Market, by Application, 2018 - 2030 (USD Million)
  • Table 86. Thailand Cell Culture Media Market, by End-use, 2018 - 2030 (USD Million)
  • Table 87. Latin America Cell Culture Media Market, by Country, 2018 - 2030 (USD Million)
  • Table 88. Latin America Cell Culture Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 89. Latin America Cell Culture Media Market, by Type, 2018 - 2030 (USD Million)
  • Table 90. Latin America Cell Culture Media Market, by Application, 2018 - 2030 (USD Million)
  • Table 91. Latin America Cell Culture Media Market, by End-use, 2018 - 2030 (USD Million)
  • Table 92. Brazil Cell Culture Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 93. Brazil Cell Culture Media Market, by Type, 2018 - 2030 (USD Million)
  • Table 94. Brazil Cell Culture Media Market, by Application, 2018 - 2030 (USD Million)
  • Table 95. Brazil Cell Culture Media Market, by End-use, 2018 - 2030 (USD Million)
  • Table 96. Mexico Cell Culture Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 97. Mexico Cell Culture Media Market, by Type, 2018 - 2030 (USD Million)
  • Table 98. Mexico Cell Culture Media Market, by Application, 2018 - 2030 (USD Million)
  • Table 99. Mexico Cell Culture Media Market, by End-use, 2018 - 2030 (USD Million)
  • Table 100. Argentina Cell Culture Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 101. Argentina Cell Culture Media Market, by Type, 2018 - 2030 (USD Million)
  • Table 102. Argentina Cell Culture Media Market, by Application, 2018 - 2030 (USD Million)
  • Table 103. Argentina Cell Culture Media Market, by End-use, 2018 - 2030 (USD Million)
  • Table 104. Middle East and Africa Cell Culture Media Market, by Country, 2018 - 2030 (USD Million)
  • Table 105. Middle East and Africa Cell Culture Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 106. Middle East and Africa Cell Culture Media Market, by Type, 2018 - 2030 (USD Million)
  • Table 107. Middle East and Africa Cell Culture Media Market, by Application, 2018 - 2030 (USD Million)
  • Table 108. Middle East and Africa Cell Culture Media Market, by End-use, 2018 - 2030 (USD Million)
  • Table 109. South Africa Cell Culture Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 110. South Africa Cell Culture Media Market, by Type, 2018 - 2030 (USD Million)
  • Table 111. South Africa Cell Culture Media Market, by Application, 2018 - 2030 (USD Million)
  • Table 112. South Africa Cell Culture Media Market, by End-use, 2018 - 2030 (USD Million)
  • Table 113. Saudi Arabia Cell Culture Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 114. Saudi Arabia Cell Culture Media Market, by Type, 2018 - 2030 (USD Million)
  • Table 115. Saudi Arabia Cell Culture Media Market, by Application, 2018 - 2030 (USD Million)
  • Table 116. Saudi Arabia Cell Culture Media Market, by End-use, 2018 - 2030 (USD Million)
  • Table 117. UAE Cell Culture Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 118. UAE Cell Culture Media Market, by Type, 2018 - 2030 (USD Million)
  • Table 119. UAE Cell Culture Media Market, by Application, 2018 - 2030 (USD Million)
  • Table 120. UAE Cell Culture Media Market, by End-use, 2018 - 2030 (USD Million)
  • Table 121. Kuwait Cell Culture Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 122. Kuwait Cell Culture Media Market, by Type, 2018 - 2030 (USD Million)
  • Table 123. Kuwait Cell Culture Media Market, by Application, 2018 - 2030 (USD Million)
  • Table 124. Kuwait Cell Culture Media Market, by End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Cell Culture Media, Market Segmentation
  • Fig. 8 Market Snapshot, 2023
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2023
  • Fig. 16 Global Cell Culture Media Market: Product Movement Analysis
  • Fig. 17 Global Cell Culture Media Market for Serum-free Media, 2018 - 2030 (USD Million)
  • Fig. 18 Global Cell Culture Media Market for Classical Media, 2018 - 2030 (USD Million)
  • Fig. 19 Global Cell Culture Media Market for Srem Cell Culture Media, 2018 - 2030 (USD Million)
  • Fig. 20 Global Cell Culture Media Market for Specialty Media, 2018 - 2030 (USD Million)
  • Fig. 21 Global Cell Culture Media Market for Chemically Defined Media, 2018 - 2030 (USD Million)
  • Fig. 22 Global Cell Culture Media Market for Other Cell Culture Media, 2018 - 2030 (USD Million)
  • Fig. 23 Global Cell Culture Media Market: Type Movement Analysis
  • Fig. 24 Global Cell Culture Media Market for Liquid Media, 2018 - 2030 (USD Million)
  • Fig. 25 Global Cell Culture Media Market for Semi-solid and Solid Media, 2018 - 2030 (USD Million)
  • Fig. 26 Global Cell Culture Media Market: Application, Movement Analysis
  • Fig. 27 Global Cell Culture Media Market for Biopharmaceutical Production, 2018 - 2030 (USD Million)
  • Fig. 28 Global Cell Culture Media Market for Diagnostics, 2018 - 2030 (USD Million)
  • Fig. 29 Global Cell Culture Media Market for Drug Screening and Development
  • Fig. 30 Global Cell Culture Media Market for Tissue Engineering and Regenerative Medicine
  • Fig. 31 Global Cell Culture Media Market for Other Applications
  • Fig. 32 Global Cell Culture Media Market: End-Use Movement Analysis
  • Fig. 33 Global Cell Culture Media Market for Pharmaceutical and Biotechnology Companies, 2018 - 2030 (USD Million)
  • Fig. 34 Global Cell Culture Media Market for Hospitals and Diagnostic Laboratories, 2018 - 2030 (USD Million)
  • Fig. 35 Global Cell Culture Media Market for Research and Academic Institutes, 2018 - 2030 (USD Million)
  • Fig. 36 Other End-users
  • Fig. 37 Regional Marketplace: Key Takeaways
  • Fig. 38 Regional Outlook, 2023 & 2030
  • Fig. 39 Global Cell Culture Media Market: Region Movement Analysis
  • Fig. 40 North America Cell Culture Media Market 2018 - 2030 (USD Million)
  • Fig. 41 U.S. Cell Culture Media Market 2018 - 2030 (USD Million)
  • Fig. 42 Canada Cell Culture Media Market 2018 - 2030 (USD Million)
  • Fig. 43 Europe Cell Culture Media Market 2018 - 2030 (USD Million)
  • Fig. 44 Germany Cell Culture Media Market 2018 - 2030 (USD Million)
  • Fig. 45 UK Cell Culture Media Market 2018 - 2030 (USD Million)
  • Fig. 46 France Cell Culture Media Market 2018 - 2030 (USD Million)
  • Fig. 47 Italy Cell Culture Media Market 2018 - 2030 (USD Million)
  • Fig. 48 Spain Cell Culture Media Market 2018 - 2030 (USD Million)
  • Fig. 49 Denmark Cell Culture Media Market 2018 - 2030 (USD Million)
  • Fig. 50 Sweden Cell Culture Media Market 2018 - 2030 (USD Million)
  • Fig. 51 Norway Cell Culture Media Market 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific Cell Culture Media Market 2018 - 2030 (USD Million)
  • Fig. 53 Japan Cell Culture Media Market 2018 - 2030 (USD Million)
  • Fig. 54 China Cell Culture Media Market 2018 - 2030 (USD Million)
  • Fig. 55 India Cell Culture Media Market 2018 - 2030 (USD Million)
  • Fig. 56 South Korea Cell Culture Media Market 2018 - 2030 (USD Million)
  • Fig. 57 Australia Cell Culture Media Market 2018 - 2030 (USD Million)
  • Fig. 58 Thailand Cell Culture Media Market 2018 - 2030 (USD Million)
  • Fig. 59 Latin America Cell Culture Media Market 2018 - 2030 (USD Million)
  • Fig. 60 Brazil Cell Culture Media Market 2018 - 2030 (USD Million)
  • Fig. 61 Mexico Cell Culture Media Market 2018 - 2030 (USD Million)
  • Fig. 62 Argentina Cell Culture Media Market 2018 - 2030 (USD Million)
  • Fig. 63 Middle East and Africa Cell Culture Media Market 2018 - 2030 (USD Million)
  • Fig. 64 South Africa Cell Culture Media Market 2018 - 2030 (USD Million)
  • Fig. 65 Saudi Arabia Cell Culture Media Market 2018 - 2030 (USD Million)
  • Fig. 66 UAE Cell Culture Media Market 2018 - 2030 (USD Million)
  • Fig. 67 Kuwait Cell Culture Media Market 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68039-957-8

Cell Culture Media Market Growth & Trends:

The global cell culture media market size is expected to reach USD 10.70 billion by 2030, registering a CAGR of 12.54% from 2024 to 2030, according to a new report by Grand View Research, Inc. Expansion of biosimilars and biologics, growth in stem cell research, and emerging bio manufacturing technologies for cell-based vaccines are the major factors which are likely to drive the market. For instance, in October 2021, the Australian Government funded the Australian-led stem cell research through USD 25 million in grants.

The expansion of clear, regulatory approval paths for biosimilars in emerging markets is generating great opportunities for biosimilar monoclonal antibodies. The availability of an approval pathway in the U.S., has led to new opportunities for bio manufacturers to enter major markets around the globe. Biosimilar versions of monoclonal antibodies have the probability to offer cost reductions of 25-30%, and many emerging market countries are vigorously developing pathways for approvals and are swiftly catching up. As this industry is expanding the key biopharmaceutical players are adopting robust culturing technologies to meet the increasing demand; thereby driving the growth of the market.

Moreover, there is growing interest in improving the stem cell culture, because this technology is being used extensively in research for studying the stem cell biology, as well as for therapeutic applications. Furthermore, funding related to this research field has augmented in recent years which has accelerated the growth of the market. In addition to this, key media manufacturers launched new products for stem cell research. For instance, in September 2021, Bio-Techne Corporation launched a novel medium for the maintenance and expansion of induced pluripotent stem cells having applications in both translational and research workflows.

The outbreak of COVID-19 pandemic has improved the demand for well-established cell-based vaccine production technologies. Moreover, it has given rise to a few scientific innovations, particularly in the production and testing of vaccine technology. For instance, the Vero line originated from the African green monkey kidney and has been extensively used for viral vaccine manufacturing. It has also been used for the development of various SARS-CoV variants. ProVeroTM1 Serum-free Medium is one such medium manufactured by Lonza Bioscience which is protein-free, and of non-animal origin designed to support the growth of Vero cells and MDCK.

Moreover, in many European countries, cell-based flu vaccines have been approved. A probable advantage of cell culture technology is that it authorizes faster start-up of the manufacturing of vaccines during the pandemic. Today, the development of superior biological models, the optimization of culture growth medium, and the reduced dependence on animal-derived components endure to drive the rapidly developing vaccine development.

On the other hand, ethical issues concerning the use of animal-derived products hinders the industry growth. For instance, FBS is collected from the blood of fetal calves is one of the major ethical issues of serum containing media. It is projected that 600,000 liters of FBS is achieved from up to 1.8 million bovine fetuses are produced globally every year, presenting momentous scientific and ethical challenges. To overcome this issue, numerous workshops were held in the past on the replacement of fetal bovine serum and possible ways to reduce the use of FBS in media.

Cell Culture Media Market Report Highlights:

  • By product, the serum-free media (SFM) segment held the highest market share of 36.0% in 2023. The use of serum-free media signifies a significant tool, which allows the researchers to perform specific applications or grow a specific cell type without using serum.
  • The biopharmaceutical production segment dominated the market with a revenue share of 42.71% in 2023. Strategic activities by key biopharmaceutical companies, increasing R&D, demand for more reproducible and better-defined media and growing biosimilars market drives the segment growth
  • By type, the liquid media segment captured the highest revenue share of 62.9% in 2023. This is attributed to increasing number of biopharmaceutical manufacturers, both downstream and upstream, are switching from premixed powders to liquid media and hence, propelling market growth
  • By end-user, The pharmaceutical and biotechnology companies segment captured the highest revenue share of 34.25% in 2023, owing to the expansion of the current manufacturing capacities coupled with increasing prevalence of chronic disease which in turn demands for novel therapeutic drugs
  • North America dominated the regional market with a revenue share of 37.58% in 2023 due to the growth in the pharmaceutical and biotechnology industry, presence of high R&D investment, and the development of novel culture media products in the region
  • Asia Pacific is estimated to grow at the fastest CAGR of 14.92% during the forecast period owing to the increase in awareness associated with the use of the cell culture technique.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Information Procurement
    • 1.3.1. Market Formulation & Data Visualization
    • 1.3.2. Data Validation & Publishing
  • 1.4. Research Assumptions
  • 1.5. Research Methodology
    • 1.5.1. Purchased Database
    • 1.5.2. Gvr's Internal Database
    • 1.5.3. 1secondary Sources
    • 1.5.4. Primary Research
    • 1.5.5. Details Of Primary Research
  • 1.6. Information Or Data Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Validation
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis (Model 1)
      • 1.8.1.1. Approach 1: Commodity Flow Approach
    • 1.8.2. Volume Price Analysis (Model 2)
      • 1.8.2.1. Approach 2: Volume Price Analysis
  • 1.9. List Of Secondary Sources
  • 1.10. Objectives
    • 1.10.1. Objective 1:
    • 1.10.2. Objective 2:
    • 1.10.3. Market Estimation For Cell Culture Media Market

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Impact Analysis
      • 3.3.1.1. Expansion Of Biosimilars And Biologics
      • 3.3.1.2. Growth In Stem Cell Research
      • 3.3.1.3. Emerging Cell Culture Technologies For Cell-Based Vaccines
    • 3.3.2. Market Restraint Impact Analysis
      • 3.3.2.1. Ethical Issues Concerning The Use Of Animal-Derived Products
      • 3.3.2.2. Stringent Regulatory Guidelines
  • 3.4. Business Environment Analysis
    • 3.4.1. Swot Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.4.2. Porter's Five Forces Analysis
  • 3.5. Recent Developments and Impact Analysis, by Key Market Participants
    • 3.5.1. Mergers and acquisitions
    • 3.5.2. Technological collaborations
    • 3.5.3. Licensing and partnerships
  • 3.6. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Product Movement Analysis & Market Share, 2023 & 2030
  • 4.2. Serum-free Media
    • 4.2.1. Global serum-free media market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.2.2. CHO Media
      • 4.2.2.1. Global CHO market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.2.3. HEK 293 Media
      • 4.2.3.1. Global HEK 293 market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.2.4. BHK Media
      • 4.2.4.1. Global BHK market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.2.5. Vero Medium
      • 4.2.5.1. Global Vero Medium market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.2.6. Other serum-free media
      • 4.2.6.1. Global other serum-free media market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.3. Classical Media
    • 4.3.1. Global Classical Media market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4. Stem Cell Culture Media
    • 4.4.1. Global Stem Cell Culture Media Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Chemically Defined Media
    • 4.5.1. Global Chemically Defined Media Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Specialty Media
    • 4.6.1. Global Speciality Media Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Other Cell Culture Media
    • 4.7.1. Global Other Cell Culture Media Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Type Business Analysis

  • 5.1. Type Movement Analysis & Market Share, 2023 & 2030
  • 5.2. Liquid Media
    • 5.2.1. Global Liquid Media Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.3. Semisolid & Solid Media
    • 5.3.1. Global Semi-Solid & Solid Media Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Application Movement Analysis & Market Share, 2023 & 2030
  • 6.2. Biopharmaceutical Production
    • 6.2.1. Global Biopharmaceutical Production Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. Monoclonal Antibodies
      • 6.2.2.1. Global Monoclonal Antibodies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Vaccines Production
      • 6.2.3.1. Global Vaccines Production Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Other Therapeutic Proteins
      • 6.2.4.1. Global Other Therapeutic Proteins Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Diagnostics
    • 6.3.1. Global Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Drug Screening & Development
    • 6.4.1. Global Drug Screening & Development Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Tissue Engineering & Regenerative Medicine
    • 6.5.1. Global Tissue Engineering & Regenerative Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Cell & Gene Therapy
      • 6.5.2.1. Global Cell & Gene Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Other Tissue Engineering & Regenerative Medicine
      • 6.5.3.1. Global Other Tissue Engineering & Regenerative Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Other Applications
    • 6.6.1. Global Other Applications Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. End-User Business Analysis

  • 7.1. Application Movement Analysis & Market Share, 2023 & 2030
  • 7.2. Pharmaceutical & Biotechnology Companies
    • 7.2.1. Global Pharmaceutical & Biotechnology Companies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Hospitals & Diagnostic Laboratories
    • 7.3.1. Global Hospitals & Diagnostic Laboratories Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Research & Academic Institutes
    • 7.4.1. Global Research & Academic Institutes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Other End-User
    • 7.5.1. Global Other End-User Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Cell Culture Media Market: Regional Estimates and Trend Analysis, by Product, Type, Application, & End-User

  • 8.1. Cell Culture Media Market: Regional Outlook
  • 8.2. North America
    • 8.2.1. North America cell culture media market, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. Key Country Dynamics
      • 8.2.2.2. Competitive Scenario
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. U.S. cell culture media market, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Competitive Scenario
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Canada cell culture media market, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe cell culture media market, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. UK cell culture media market, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Germany cell culture media market, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. France cell culture media market, 2018 - 2030 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Competitive Scenario
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Italy cell culture media market, 2018 - 2030 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Competitive Scenario
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Spain cell culture media market, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Competitive Scenario
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Denmark cell culture media market, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Competitive Scenario
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Sweden cell culture media market, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Competitive Scenario
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Norway cell culture media market, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific cell culture media market, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Japan cell culture media market, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. China cell culture media market, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. India cell culture media market, 2018 - 2030 (USD Million)
    • 8.4.5. Singapore
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Singapore cell culture media market, 2018 - 2030 (USD Million)
    • 8.4.6. Australia
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Australia cell culture media market, 2018 - 2030 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Thailand cell culture media market, 2018 - 2030 (USD Million)
    • 8.4.8. South Korea
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. South Korea cell culture media market, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America cell culture media market, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Brazil cell culture media market, 2018 - 2030 (USD Million)
    • 8.5.3. Mexico
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Mexico cell culture media market, 2018 - 2030 (USD Million)
    • 8.5.4. Argentina
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Argentina cell culture media market, 2018 - 2030 (USD Million)
  • 8.6. MEA
    • 8.6.1. MEA cell culture media market, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. South Africa cell culture media market, 2018 - 2030 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Saudi Arabia cell culture media market, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. UAE cell culture media market, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Kuwait cell culture media market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2023
  • 9.4. Company Profiles/Listing
    • 9.4.1. Sartorius AG
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Danaher
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Merck KGaA
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Thermo Fisher Scientific, Inc.
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. FUJIFILM Corporation
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Lonza
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. BD
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. STEMCELL Technologies
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Cell Biologics, Inc.
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. PromoCell GmbH
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives